We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Antaco is a company that deals in waste management by converting it into neutral solid biofuel using their patented technology. The global water sector is estimated to present a £15 billion opportunity. To date, the company has raised £5.8 million, including an £857,000 grant from the UK government and has also signed a contract with its first customer (Swiss Public Utility). With the proceeds, the company will build up their in-house capacity, increase enhancement of existing plant and hire subcontractors to install and commission plant.

Pitch Rated

77%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £570,840
Creative Hub is a fast-growing cloud software platform for creative people to store, share files, and collaborate on projects. The collaboration tools also allow users to chat in real-time, and add comments on images, allowing creative teams to work faster and deliver better results. Creative Hub enables users to order professional art & photographic prints, or physical 3D prints, which are produced at its print production facilities in London(UK) and Dusseldorf (Germany). The platform currently has 40,000 active users which are growing day by day. With the investment, the company will drive growth through marketing and launch its New York production facility.

Pitch Rated

76%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £286,992
Rightangled is a DNA testing company backed by NHS that delivers services to consumers and medical/fitness specialists. The company is a full CQC healthcare provider license that has achieved registration with Bupa, a leading medical insurance company. The company is now planning to move into AI with a solid database. Rightangled has received excellent customer reviews with 5* on Google and 4.5* on Trustpilot. With the proceeds, the company will seek to launch its application, create a strong AI central system, and grow into new markets (US& UAE).

Pitch Rated

75%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £311,690
Sol-Gel Materials and Application (SGMA) is a sustainable technology company that is using its new sol-gels to create sustainable solutions to plastic environmental waste. The company has researched and developed a non-plastic, non-toxic coating for products, from food packaging to electronics, that is water and oil resistant yet recyclable. Its product is the world’s only biodegradable, compostable, and recyclable (BCR) solution. The company's founder and CEO, Dr Fanya Ismail, has won the award 'Women in Innovation 2019' by Innovate UK and the company's work has been covered by BBC South East Today. The company plans to function as an IP management company, sub-contract manufacturing to chemical firms moving from bulk to advanced materials, and outsource distribution to partners, whose packaging customers serve brand owners.

Pitch Rated

72%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £611,040
Accunea is the world’s first real-time continuous organ function monitoring company, specializing in biomarkers for kidney transplantation. Targeting NHS hospitals in the UK undertaking renal transplantation, the company aims to provide relief to patients awaiting organ transplants by ensuring availability of more organs for transplant and reducing the numbers of deaths due to increasing waiting list times. For this purpose, the company has designed a miniature analysis device which constantly monitors markers of kidney function and metabolism through a standard dribble line put into the vein of a patient. Accunea is raising £400,000 at a pre-money valuation of £2,230,000. The funds will be used to achieve clinical utility in Kidney and Pancreas.

Pitch Rated

71%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £388,038
Polysolar specialises in manufacturing photovoltaic windows capable of generating electricity, which can be used in buildings to generate clean renewable energy whilst also meeting planning regulations. Its technology is already in-use by major organisations such as Network Rail and Sainsbury's.

Pitch Rated

69%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £1,311,180
VPS work with vehicle manufacturers to provide labour such as fitting air conditioning, leather seats, etc. to their cars as they arrive at port from overseas. VPS's main focus is the manufacturing of Number Plates within the Approved British Standard and selling these directly to the car manufacturers.

Pitch Rated

62%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £851,620
EnXray are developing Low Energy X-ray (LEXR) technologies to sterilise equipment in commercial or research settings where low volume/high value therapeutic products, such as cancer vaccines and stem cell implants are being developed. Their aim is to reduce the need for third party providers and have the sterilisation process done on-site and on-demand with simple and safe equipment to reduce cost and save time for medical research organisations.

Pitch Rated

61%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £376,230
TC BioPharm is an immunotherapy company. It has used its patented technology to harness the power of a particular part of the immune system, Gamma Delta T-cells (GDT), to negate cancer cells in the human body. TC BioPharm has treated terminally ill patients with acute myeloid leukaemia in approved clinical trials garnering positive responses from multiple patients. The company has received regulatory approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to run a COVID-19 clinical trial to address the global pandemic. TC BioPharm aims to use its current technology to provide a frozen product that can be manufactured cost-effectively and distributed globally. The company has already raised over £7 million in the last 15 months. It will use the investment to take its clinical trials forward in COVID-19 and cancer.

Pitch Rated

59%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,753,067
Gravitricity is an energy technology company. The company uses winches to raise a heavyweight to the top of a vertical shaft to store electricity in the form of potential energy when there is excess energy on the grid. It then lowers it when required with the winch motors running as generators to transfer energy back to users on the grid. Gravitricity argues that the system can be charged and discharged multiple times a day for over 25 years. The company has built a 250kW concept demo in Edinburgh. It aims to become a contender in the energy storage market that is set to be worth $620 billion by 2040. The company has received interest from operating mines, grid companies, EV charging stations and solar developers for its technology. It is also investigating project sites in UK, Europe, the USA and South Africa. It will use the investment to complete the concept and detailed design for its prototype, develop its commercial projects portfolio, and protect its Intellectual Property (IP).

Pitch Rated

58%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £2,124,008
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph